Protective effects of Antrodia camphorata extract against hypoxic cell injury and ischemic stroke brain damage

Zwe‐Ling Kong,Ya‐Ting Hsu,Athira Johnson,Tung‐Han Tsai,Song Miao,Jia‐Ling He,David Tsou
DOI: https://doi.org/10.1002/ptr.6928
IF: 6.388
2020-10-25
Phytotherapy Research
Abstract:<p>Ischemic stroke is the most prevalent stroke condition in the world resulted in either a transient ischemic attack or long‐lasting neurological problems due to the interrupted or reduced blood flow to the brain. <i>Antrodia camphorata</i> is a well‐known medicinal mushroom native to Taiwan and is familiar due to its medicinal effects. The current study investigated the protective effect of <i>A. camphorata</i>‐alcohol extracts (AC‐AE) against cobalt (II) chloride (CoCl<sub>2</sub>)‐induced oxidative stress in vitro and ischemia/reperfusion‐induced brain injury in vivo. The rats were pre‐treated with AC‐AE for 4 weeks. Our results showed that AC‐AE reduced cell damage and decreased reactive oxygen species (ROS) production in C6 and PC12 cells under CoCl<sub>2</sub>‐induced hypoxic condition. AC‐AE doses (385, 770, 1,540 mg/kg/day, 4 weeks) increased nuclear factor erythroid 2–related factor 2 (Nrf2) and heme oxygenase‐1 (HO‐1) mRNA expressions and decreased inducible nitric oxide synthase (iNOS) and cyclooxygenase‐2 (COX‐2) mRNA expressions in Sprague Dawley rat. Besides, it decreased stroke infarct size and increased the level of antioxidants in both brain and serum. Furthermore, it reduced the formation of malondialdehyde (MDA) after ischemia/reperfusion (I/R). Our results suggested that AC‐AE exerted an effective reduction of ischemia stroke by regulating ROS production.</p>
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the protective effects of the alcohol extract (AC - AE) of Taiwan - specific medicinal fungus **Antrodia camphorata** (*Antrodia camphorata*) on hypoxic cell damage and brain damage in ischemic stroke. Specifically, the researchers hope to experimentally verify whether AC - AE can reduce cell damage caused by cobalt (II) chloride (CoCl₂) - induced oxidative stress in vitro, and whether it can alleviate brain damage caused by ischemia/reperfusion in vivo. ### Main research questions: 1. **In vitro study**: - Can AC - AE reduce cell damage in C6 glioma cells and PC12 pheochromocytoma cell lines induced by CoCl₂? - Can AC - AE reduce the generation of reactive oxygen species (ROS) in these cells? 2. **In vivo study**: - Can AC - AE reduce the volume of cerebral infarction caused by ischemia/reperfusion (I/R)? - Can AC - AE increase the activity of antioxidant enzymes (such as glutathione peroxidase GPx, superoxide dismutase SOD and catalase CAT)? - Can AC - AE reduce the production of lipid peroxidation products (such as malondialdehyde MDA)? - Can AC - AE regulate the expression of inflammatory mediators (such as inducible nitric oxide synthase iNOS and cyclooxygenase - 2 COX - 2) and antioxidant response genes (such as nuclear factor erythroid 2 - related factor 2 Nrf2 and heme oxygenase - 1 HO - 1)? ### Research methods: - **In vitro experiments**: Use C6 glioma cells and PC12 pheochromocytoma cell lines, detect cell viability by MTT method, and detect ROS generation by DCFH - DA staining and flow cytometry. - **In vivo experiments**: Use Sprague Dawley rats, simulate ischemic stroke by middle cerebral artery occlusion (MCAO) model, and evaluate the effects of AC - AE on cerebral infarction volume, antioxidant enzyme activity and inflammatory mediator expression. ### Expected results: - It is expected that AC - AE can significantly reduce CoCl₂ - induced cell damage and ROS generation. - It is expected that AC - AE can reduce the volume of cerebral infarction, increase the activity of antioxidant enzymes, and reduce the expression of inflammatory mediators. Through these studies, the paper aims to provide a scientific basis for the potential application of Antrodia camphorata in the prevention and treatment of ischemic stroke.